DH Company Profile and Key Details

Definitive Healthcare Corp. (NASDAQ:DH) closed at $2.52 USD, losing -$0.02 (-0.59%) from the previous close of $2.54. The stock is currently mid-range between its 52-week high and low $2.15 and $5.68. With a market capitalization of about $260.84 million, Definitive Healthcare Corp. is classified as a micro-cap and shows higher-than-market volatility (beta ~1.61). Key stats such as the average daily volume over the past year has been around 362.70 thousand shares, in line with its 52-week average. Headquartered in Framingham, MA, Definitive Healthcare Corp. operates in the Healthcare sector and the Medical - Healthcare Information Services industry. Led by CEO Kevin D. Coop, the company employs approximately 782 people and listed since September 15, 2021. Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States.

DH has shown mixed momentum, gaining 10.43% over the past week and -39.67% over the past quarter, though year-to-date performance is down -38.2%. Short-term trend indicators are bullishly aligned (SMA20 0.32%, SMA50 -6.31%, SMA200 -22.73%). The stock’s 14-day RSI is 48.55 (neutral), while the ATR of 0.15 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -55.28% below its high and over 18.14% above its low. Average 10-day trading volume of 729.75 thousand shares is significantly above the 3-month average of 334.95 thousand, indicating heightened recent market interest.

Definitive Healthcare Corp. generated EPS of -$1.68 over the past year. Five-year average earnings growth is -70.74%. Wall Street analysts project EPS growth of -6.8% annually over the next five years. The latest quarter delivered EPS of $0.07. The next quarter is forecast at $0.06. Next year's EPS is expected at $3.31. Analyst sentiment is bearish. Analyst rating data shows there are 0 Strong Buy ratings, 1 Buy ratings, 2 Hold ratings, 0 Sell rating and 3 Strong Sell ratings. Price targets range from $6.00 to $3.00. The high target offers 136.22% upside. The low target suggests 18.11% downside. The mean target is $3.83. This offers 50.79% upside. Definitive Healthcare Corp. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended November 06, 2025, missed forecasts by 16.67%. The prior quarter beat by 40.0%. Over the last six quarters, Apple has recorded several small beats. These include 0.0% in August 05, 2024.

Definitive Healthcare Corp. has 104.09 million shares outstanding. The public float is 38.50 million shares, elevated short interest at 10.03% of float. This equals 4.03 million shares. The short ratio is 8.33 days. Institutional investors hold 105.87% of the float. Insiders own 9.42%. Spectrum Equity Associates VII, L.P. holds 2.51 million shares, SEA VII Management, LLC has 1.44 million shares and Krantz Jason Ronald has 450.00 thousand shares.

Definitive Healthcare Corp. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $10.10. This means the shares are trading below this model’s fair value.

Our AI price prediction model suggests that Definitive Healthcare Corp. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -11.81%, with price expected at $2.24 by January 02, 2026, within a range of $2.14 to $2.33 3-Month Outlook: Projected fall of -66.93%, reaching $0.84 by March 19, 2026, with a range of $0.73 to $0.94. 1-Year Outlook: Projected gain of 90.55%, with price at $4.84 by December 18, 2026, within a range of $0.00 to $5.69.

Definitive Healthcare Corp. (NASDAQ:DH) shares are down -38.2% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Definitive Healthcare Corp. trading at a premium to the broader market with a P/E of -1.4. Analyst sentiment is cautious, with the majority of ratings in Underweight territory and a mean price target of $14.87, suggesting 485.43% upside. Our AI forecast model points to short-term weakness (-11.81% over two weeks), a medium-term fall (-66.93% over three months), and a longer-term gain (90.55% over one year), with expected trading ranges indicating moderate volatility.

Definitive Healthcare Corp. trades at a P/E ratio of -1.4, slightly below the S&P 500 average, with a price-to-sales ratio of 1.08 and a price-to-book ratio of 0.68 suggesting the stock is closer to book value. The P/FCF stands at 5.43, also above market averages.